Clinical trials

Clinical trials

A clinical trial is a scientific research study designed to find out how to keep improving treatment. 

Key points to remember

  • research into new methods of treating cancer is happening all the time
  • researchers may look at new medicines, a new combination of medicines or a new surgical procedure
  • they do this by using a clinical trial
  • clinical trials have played a huge role in the dramatic improvements in childhood cancer cure rates in the last 30 to 40 years

What is a clinical trial?

This page is part of a whole section about childhood cancer.

A clinical trial is a scientific research study designed to find out how to keep improving treatment. Clinical trials may provide more information about well-established types of treatment. Or, they may look at new treatments developed in the laboratory and work out the benefits or drawbacks.

Research into new methods of treating cancer is happening all the time. Researchers may look at new medicines, a new combination of medicines or a new surgical procedure. They do this by using a clinical trial. Many hospitals around the world are involved in each clinical trial. This means that researchers can look at results from a large number of patients and get a better idea of the success of the treatment. Clinical trials have played a huge role in the dramatic improvements in childhood cancer cure rates in the last 30 to 40 years.

What are the different types of trials?

There are 3 phases of a clinical trial.

Phase 1 trials

These study brand new medicines.

Phase 2 trials

These study medicines which have graduated from phase 1 trials. Researchers test the medicines with a greater number of people and sometimes with different doses.

Phase 3 trials

These are the ones that most children are enrolled in. Researchers compare what has been used as the 'standard treatment' with a new form of treatment. In this way, the trial is a refinement rather than experimentation.

How are phase 3 trials applied?

To make comparisons between treatments, patients in a trial receive one treatment or the other. This means that one group of children will receive 'treatment A' and another group will receive 'treatment B'. Sometimes there are more than 2 groups. A computer makes the selection. The computer has no information about your child - the decision is random.

What about the results?

The results of the research and treatment will not be available until all the patients have completed the treatment course. This may take several years. But researchers regularly review the records during the trial. If they discover important information, they tell each doctor involved. That way, they share all the findings.

Does my child have to join a clinical trial?

You do not have to consent to your child joining a clinical trial. If you do, you can withdraw your child from the trial at any time. If this happens, your child will receive the standard treatment.

How do I make a decision about my child joining a clinical trial?

Your child's doctor will explain everything to you and provide all the information you need to help you to make an informed decision.

Also, there is an information sheet for each clinical trial. It details the course of treatment (called the protocol), possible side-effects and any necessary tests. It will also tell you what information and specimens will be collected and sent to the overseas centre.

Questions to ask your doctor

Here are some of the questions you may wish to ask your doctor. You may also want some of the medical terms explained.

  1. What type of trial is this and why is it being done?
  2. What exactly will the researchers do during this trial?
  3. How long will the trial last?
  4. How will it affect us – are there any extra tests or hospital visits?
  5. What are the benefits and risks and other available treatments?

What safeguards are in place?

There are safeguards in place to protect patients participating in clinical trials. The 3 main ones are:

  1. Informed consent.
  2. Deciding if a clinical trial is safe.
  3. NZ specific safeguards.

What is informed consent?

Informed consent is a process. Your doctor and other health professionals will share information and advice with you and your child. The information and advice will help you both to decide whether or not to consent to being part of a clinical trial.

The ethical basis for the principle of informed consent comes from Right 7 of the Code of Health and Disability Services Consumers' Rights. You can ask for a copy of the Code at your hospital.

Who's involved in deciding if a clinical trial is safe?

Most clinical trials for childhood cancer treatment are designed by large paediatric oncology (children's cancer) groups. The groups that the Children's Cancer Services in New Zealand are associated with are:

  • COG (Children's Oncology Group) in the USA
  • CCLG (The Children's Cancer and Leukaemia Group) in the UK
  • ANZCHOG (Australia and New Zealand Children's Haematology and Oncology Group)
  • SIOP (International Society of Paediatric Oncology)

What about NZ specific safeguards?

Every clinical trial requires careful assessment by an ethics committee. It is the responsibility of the committee to make sure that it is ethically acceptable for children to participate in the trial. Even though most clinical trials are developed overseas, a New Zealand ethics committee must review each trial before it is approved in this country.

In New Zealand, clinical trials are also reviewed for cultural acceptance by a Maori consultant or by a Health Research Committee which is Iwi representative.

All the pages in the childhood cancer section of this website have been written by health professionals who work in the field of paediatric oncology. They have been reviewed by the members of the National Child Cancer Network (NZ). Medical information is authorised by the clinical leader of the National Child Cancer Network.

This page last reviewed 10 August 2018.
Email us your feedback


On this page